Total Funding
60
49
Total FundingGrant raised
Growth Score
-8 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
170962
Microvascular Therapeutics is a biotechnology company specializing in ultrasound contrast and theranostics for diagnosis.
- Wyatt Unger: Chief Executive Officer and Chief Medical Officer
Dr. Evan C. Unger: Founder, Interim Chief Executive Officer and Consultant
About the Company
Microvascular Therapeutics develops MVT-100, a new, patented ultrasound contrast agent. It may serve as a platform for developing agents for molecular imaging and image-guided therapy due to its neutral surface chemistry. Microvascular Therapeutics-100 has a neutral surface chemistry and could be used to develop agents for molecular imaging and
image-guided therapy. The company has created an accelerated development path that could lead to MVT-100 approval for echocardiography.
